Search
Search Results
Found 12 items.
-
Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience
Published: December 31, 20171442PDF: 758 -
Blue light cystoscopy with hexylaminolevulinate: Our 7 years experience
Published: March 31, 20171534PDF: 787 -
Non-muscle invasive high grade urothelial carcinoma of the bladder. Which factors can influence understaging at the time of radical cystectomy?
Published: March 31, 20162405PDF: 1350 -
Prognostic impact of ReTURB in high grade T1 primary bladder cancer
Published: July 4, 20162149PDF: 1255 -
Effectivity of intravescical thermo-chemotherapy prophylaxis for patients with high recurrence and progression risk for non-muscle invasive bladder cancer
Published: June 30, 20172038PDF: 1140 -
Anthropometric characteristics and relationship with non-muscle invasive bladder cancer in Greece: A case-control study
Published: March 15, 2023748PDF: 314 -
History of infantile BCG immunization did not predict lamina propria invasion and/or high-grade in patients with non-muscle invasive bladder cancer
Published: May 31, 2023628PDF: 374 -
Bacillus Calmette-Guerin vaccine and bladder cancer incidence: Scoping literature review and preliminary analysis
Published: March 18, 20211481PDF: 962Supplementary Material: 150 -
New concept in urologic surgery: The total extended genital sparing radical cystectomy in women
Published: May 22, 20231519PDF: 647 -
Patterns of treatment of high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) patients among Arab urologists
Published: March 19, 20241012PDF: 241 -
Office-based management of Non-Muscle Invasive Bladder Cancer (NMIBC): A position paper on current state of the art and future perspectives
Published: March 19, 2024276PDF: 211
1 - 12 of 12 items